Hyperthermia, positive feedback loop with IL-6 and risk of NSCLC progression: a tangle to unravel?
- PMID: 31807866
- PMCID: PMC11804290
- DOI: 10.1007/s00432-019-03105-9
Hyperthermia, positive feedback loop with IL-6 and risk of NSCLC progression: a tangle to unravel?
Abstract
Fever may represent a risk factor for NSCLC by increasing IL-6 expression. In this light, an accurate and rapid control of fever among lung cancer patients should be carefully added to the treatment plan. On this regard, concerns increase when doubts arise regarding the applicability of hyperthermia on NSCLC given the potential interaction of IL-6 with NSCLC. Thus, I suggest that randomized, controlled double-arm clinical studies are warranted for an evidence-based evaluation of feasibility of the hyperthermia application in the management of NSCLC.
Conflict of interest statement
The author declares no potential conflicts of interest.
Similar articles
-
Exercise intervention to improve exercise capacity and health related quality of life for patients with Non-small cell lung cancer: a systematic review.Lung Cancer. 2011 May;72(2):139-53. doi: 10.1016/j.lungcan.2011.01.006. Epub 2011 Feb 12. Lung Cancer. 2011. PMID: 21316790
-
Erlotinib and gefitinib for treating non-small cell lung cancer that has progressed following prior chemotherapy (review of NICE technology appraisals 162 and 175): a systematic review and economic evaluation.Health Technol Assess. 2015 Jun;19(47):1-134. doi: 10.3310/hta19470. Health Technol Assess. 2015. PMID: 26134145 Free PMC article.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Targeted therapy for advanced anaplastic lymphoma kinase (<I>ALK</I>)-rearranged non-small cell lung cancer.Cochrane Database Syst Rev. 2022 Jan 7;1(1):CD013453. doi: 10.1002/14651858.CD013453.pub2. Cochrane Database Syst Rev. 2022. PMID: 34994987 Free PMC article.
-
Gefitinib for advanced non-small cell lung cancer.Cochrane Database Syst Rev. 2018 Jan 16;1(1):CD006847. doi: 10.1002/14651858.CD006847.pub2. Cochrane Database Syst Rev. 2018. PMID: 29336009 Free PMC article.
Cited by
-
Paracrine Factors Released from Tonsil-Derived Mesenchymal Stem Cells Inhibit Proliferation of Hematological Cancer Cells Under Hyperthermia in Co-culture Model.Appl Biochem Biotechnol. 2024 Jul;196(7):4105-4124. doi: 10.1007/s12010-023-04757-7. Epub 2023 Oct 28. Appl Biochem Biotechnol. 2024. PMID: 37897623
References
-
- Bouchama A, al-Sedairy S, Siddiqui S, Shail E, Rezeig M (1993) Elevated pyrogenic cytokines in heatstroke. Chest 104(5):1498–1502 - PubMed
-
- Chang JC (1987) How to differentiate neoplastic fever from infectious fever in patients with cancer: usefulness of the naproxen test. Heart Lung 16(2):122–127 - PubMed
-
- Coulon L, Bienvenu J, Gutowski MC, Barbier Y, Barbier M, Panteix G, Gilly FN, Carry PY, Sayag A, Braillon G (1993) Cytokine production during intraperitoneal chemohyperthermia. Oncology 50(5):371–374 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical